Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Journal of Neuroinflammation
|
November 5, 2024
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Stefano Angiari, Tommaso Carlucci, Simona L Budui, et al.
Brain : a Journal of Neurology
|
December 20, 2023
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5
Ilaria Callegari, Johanna Oechtering, Mika Schneider, et al.
Vaccine
|
August 29, 2025
Altered immune responses to mRNA vaccination against SARS-COV-2 are characterized by an impaired cross-talk between humoral and T-cellular immune compartments in patients with hematologic diseases
Stefan Hatzl, Florian Posch, Eduard Schulz, et al.
Frontiers in Immunology
|
April 3, 2026
Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study
Marie Süße, Malte Johannes Hannich, Felix Lottermoser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 3, 2014
Determinants of iron accumulation in deep grey matter of multiple sclerosis patients
Stefan Ropele, Iris D Kilsdonk, Mike P Wattjes, et al.
Neurogenetics
|
March 14, 2012
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients
Mascha C Schmied, Sonja Zehetmayer, Markus Reindl, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 20, 2016
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Harald Hegen, Indra Adrianto, Christopher J Lessard, et al.
Nature Reviews. Neurology
|
April 12, 2024
Neurofilaments as biomarkers in neurological disorders - towards clinical application
Michael Khalil, Charlotte E Teunissen, Sylvain Lehmann, et al.
Ebiomedicine
|
May 28, 2026
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis
Elena Ellmeier, Alyssa Schnabl, Julia Meissel, et al.
Journal of Neurology
|
October 19, 2023
Multiple sclerosis in the elderly: a retrospective cohort study
Anne Zinganell, Georg Göbel, Klaus Berek, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Journal of Neuroinflammation
|
November 5, 2024
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Stefano Angiari, Tommaso Carlucci, Simona L Budui, et al.
Brain : a Journal of Neurology
|
December 20, 2023
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5
Ilaria Callegari, Johanna Oechtering, Mika Schneider, et al.
Vaccine
|
August 29, 2025
Altered immune responses to mRNA vaccination against SARS-COV-2 are characterized by an impaired cross-talk between humoral and T-cellular immune compartments in patients with hematologic diseases
Stefan Hatzl, Florian Posch, Eduard Schulz, et al.
Frontiers in Immunology
|
April 3, 2026
Kappa free light chains in cerebrospinal fluid to detect inflammation - results from a multicentric prospective real-world study
Marie Süße, Malte Johannes Hannich, Felix Lottermoser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 3, 2014
Determinants of iron accumulation in deep grey matter of multiple sclerosis patients
Stefan Ropele, Iris D Kilsdonk, Mike P Wattjes, et al.
Neurogenetics
|
March 14, 2012
Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients
Mascha C Schmied, Sonja Zehetmayer, Markus Reindl, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 20, 2016
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Harald Hegen, Indra Adrianto, Christopher J Lessard, et al.
Nature Reviews. Neurology
|
April 12, 2024
Neurofilaments as biomarkers in neurological disorders - towards clinical application
Michael Khalil, Charlotte E Teunissen, Sylvain Lehmann, et al.
Ebiomedicine
|
May 28, 2026
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis
Elena Ellmeier, Alyssa Schnabl, Julia Meissel, et al.
Journal of Neurology
|
October 19, 2023
Multiple sclerosis in the elderly: a retrospective cohort study
Anne Zinganell, Georg Göbel, Klaus Berek, et al.
Page
of 13